Be part of an industry that will change the way the world delivers its health outcome

“There’s a lot to like about what Medical Kiwi is setting out to achieve. I like the idea of supporting a local company that is starting from scratch. I like the idea of employing and upskilling local people. And I like the health benefits that medical cannabis can provide.” – Shane Adamson, Medical Kiwi shareholder.

Until recently, cannabis has been a globally prohibited substance with the vast majority of people unaware of its medicinal properties and those who have wanted to use it facing crippling costs and zero or severely restricted supply. Scientists believe the chemical molecules in cannabis can provide a range of physical and psychological health benefits. Medicinal cannabis is in demand overseas in Western countries who have already legalised the cultivation, production and use of the product, and as scientists continue to learn more about its therapeutic benefits and pharmaceutical uses, the demand is increasing. Read more about Medicinal cannabis and CBD.

Significant changes in New Zealand’s legislation have paved the way for the creation of a fully commercialised medical cannabis and CBD industry. A major opportunity now exists for companies to leverage New Zealand’s provenance, reputation for innovation and areas of competitive advantage to cultivate, produce and sell medicinal cannabis and CBD wellbeing products domestically and globally.

Medical Kiwi is in a unique position as one of a handful of New Zealand companies poised to create value and carve out a significant share of this emerging and exciting growth industry. The global opportunity that medicinal cannabis represents is estimated to reach USD $150 billion by 2025. (Grand View Research, April 2018)

Against the backdrop of a global health and wellness consumer mega-trend, and with sentiments and legislation towards alternative medicines, and medicinal cannabis in particular, rapidly evolving, the time is now to participate in the opportunity that Medical Kiwi represents.

We’re delivering results

In just under one year we’ve already started delivering results, with a clear plan to keep achieving milestones. This puts us in the premier position to realise the global opportunities for safe, high-quality, consistent, affordable medicinal cannabis and CBD wellness products to bring real change to people’s lives and health outcomes.

Established in December 2018, we’ve achieved a lot in a short time! We have:

  • developed a clear strategy for research, manufacturing, marketing, sales and distribution
  • built a strong health-based and scientific team with vast knowledge and expertise
  • successfully raised our initial seed fund capital
  • secured a greenfield site and developed detailed plans for our state-of-the-art facility in Nelson
  • signed partnership agreements with global industry-leading companies
  • been granted a licence to cultivate from the Ministry of Health with further licences pending.

What makes us different?

  1. New Zealand Provenance: Leveraging the marketable clean, green, healthy New Zealand branding provenance and our fully integrated “seed-to-sale” proposition.
  2. Cultivation and Medicinal Product IP: Our focus is on medical research to create unique products that derive higher margins than most other competitors. The goal is certification of standardisation of the beneficial bioactive properties of extracts and this will lead to the development of a portfolio of Medical Kiwi proprietary products.
  3. Strategic Partnerships: We have established strong international networks with world-leading partners which include exclusive distribution rights for leading brands ensuring Medical Kiwi has revenue while our state-of-the-art facility is being built, delivering shareholder returns and faster growth.
  4. Uptake Agreements for future sales: We have secured uptake agreements with global companies to supply our unique Medical Kiwi grown product for sale and distribution. This means we can plan our production with certainty.

The offer

Medical Kiwi is seeking to raise investment capital to support our business strategy. All shares on offer are full ordinary shares and their sale will be managed over three stages.

Complete
Medical Kiwi successfully completed seed funding in mid 2019. During this phase 100,000 shares were offered for sale to early investors, raising an initial NZD $1 million in investment capital. This has enabled Medical Kiwi to secure a greenfield site, complete design plans for a state-of-the-art facility and apply for licences.

Current
Started in July 2019 with the intention to raise NZD $2.5 million. This will be achieved through the sale of 83,334 shares at a price of $30 per share for private wholesale investors and high net worth individuals.

Coming soon
Medical Kiwi plan to pursue further investment in 2020 to raise NZD $2 million.

Use of funds

Research and development $700,000
Administration and operations $1,100,000
Sales and distribution $650,000
Product development and marketing $550,000
Plant and equipment lease $1,500,000
TOTAL $4,500,000

Find out more about your chance to be a part of a global industry that will change the shape of the way the world delivers its health outcomes.

Register your interest

Find out more about your chance to be a part of a global industry that will change the shape of the way the world delivers its health outcomes.

FACT

A poll commissioned by the New Zealand Drug Foundation in 2018 found that 87% of New Zealanders now support medicinal cannabis for the treatment of pain and 89% support the use of medicinal cannabis as terminal pain relief.

Our Information Memorandum for investors

Invest with us